PIK3CA and hepatocellular carcinoma: PIK3CA mutations have also been reported in several malignancies such as breast cancer, head and neck cancer, glioblastoma, gastric cancer, lung cancer, prostate cancer, anal canal cancer, hepatocellular cancer, colorectal cancer, endometrial cancer, and cervical cancer24,27.